Epi Pharmaceutical is categorized under Wholesale Pharmaceutical Products in Kennewick, WA .
Epi Pharmaceutical was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Patricia Murray, Manager at the company’s single location by writing to 21309 East 25th Avenue, Kennewick, Washington WA 99337 or by phoning (425) 481-0696. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Epi Pharmaceutical |
| Contact Person: | Patricia Murray, Manager |
| Address: | 21309 East 25th Avenue, Kennewick, Washington 99337 |
| Phone Number: | (425) 481-0696 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Epi Pharmaceutical was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Patricia Murray, Manager for inquiries that concern Epi Pharmaceutical by calling the company number (425) 481-0696, as your correspondence is most welcome. Additionally, the physical location of the single location of Epi Pharmaceutical can be found at the coordinates 46.17959,-119.11546 as well as the street address 21309 East 25th Avenue in Kennewick, Washington 99337.
For its online presence, you may visit Epi Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.